(Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | (FY)Mar 31, 2022 | (Q4)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 23.53%-14.05K | -338.52%-51.32K | 57.95%-18.53K | -208.93%-94.14K | -203.62%-20.01K | 35.70%-18.37K | -26.69%-11.7K | -267.66%-44.05K | 53.75%-30.47K | 168.09%19.31K |
Net income from continuing operations | -4.25%-60K | -34.53%-105.68K | 11.08%-37.96K | -243.57%-607.92K | -947.12%-429.12K | -101.48%-57.56K | -99.57%-78.55K | 37.26%-42.69K | 40.91%-176.94K | 80.00%-40.98K |
Asset impairment expenditure | ---- | ---- | ---- | --382.05K | ---- | ---- | ---- | ---- | --0 | ---- |
Remuneration paid in stock | --3.4K | ---- | ---- | -45.20%17.55K | --0 | --0 | ---- | ---- | --32.03K | --0 |
Other non cashItems | 3.75%28.93K | -49.89%24.9K | 117.74%34.67K | --124.48K | --31K | 77.08%27.88K | 219.11%49.68K | 1.47%15.92K | ---- | ---- |
Change In working capital | -102.95%-333 | -1,478.85%-6.05K | 11.86%-15.24K | -109.00%-10.3K | -103.67%-3.94K | 171.81%11.31K | -102.63%-383 | -307.48%-17.29K | 52.97%114.44K | 501.18%107.3K |
-Change in receivables | 979.89%9.54K | -163.24%-2.59K | 88.12%-126 | -46.13%-4.21K | -11.50%-1.09K | ---1.08K | -68.44%-982 | 19.98%-1.06K | -188.63%-2.88K | -170.56%-974 |
-Change in payables and accrued expense | -179.66%-9.87K | -677.96%-3.46K | 6.88%-15.11K | -105.19%-6.09K | -102.64%-2.85K | 178.70%12.39K | -96.04%599 | -268.01%-16.23K | 63.95%117.32K | 494.65%108.27K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -52.51%-28.02K | -338.52%-51.32K | 57.95%-18.53K | -208.93%-94.14K | -203.62%-20.01K | 35.70%-18.37K | -26.69%-11.7K | -267.66%-44.05K | 53.75%-30.47K | 168.09%19.31K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | ||||||||||
Cash from discontinued investing activities | ||||||||||
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 235.96%65.31K | 0 | 997.72%192.1K | 2,433.22%126.66K | 1K | 288.80%19.44K | 500.00%45K | -73.68%17.5K | -81.48%5K |
Net issuance payments of debt | --0 | --65.31K | --0 | -385.15%-203.77K | -5,095.30%-249.77K | --1K | --0 | 186.54%45K | -163.16%-42K | -81.48%5K |
Net common stock issuance | ---- | ---- | ---- | --376.43K | ---- | ---- | ---- | ---- | --0 | ---- |
Proceeds from stock option exercised by employees | --0 | ---- | ---- | -67.33%19.44K | --0 | --0 | ---- | ---- | --59.5K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | 235.96%65.31K | --0 | 997.72%192.1K | 2,433.22%126.66K | --1K | 288.80%19.44K | 500.00%45K | -73.68%17.5K | -81.48%5K |
Net cash flow | ||||||||||
Beginning cash position | 478.58%102.46K | 787.27%88.46K | 1,085.71%106.99K | -58.98%9.02K | 102.22%339 | 33.38%17.71K | -43.07%9.97K | -58.98%9.02K | -7.87%22K | -165.46%-15.29K |
Current changes in cash | 19.13%-14.05K | 80.85%13.99K | -2,056.28%-18.53K | 855.20%97.96K | 338.63%106.65K | 39.20%-17.37K | 282.63%7.74K | 121.13%947 | -590.00%-12.97K | 1,879.94%24.31K |
End cash Position | 25,979.35%88.41K | 478.58%102.46K | 787.27%88.46K | 1,085.71%106.99K | 1,085.71%106.99K | 102.22%339 | 33.38%17.71K | -43.07%9.97K | -58.98%9.02K | -58.98%9.02K |
Free cash from | -52.51%-28.02K | -338.52%-51.32K | 57.95%-18.53K | -208.93%-94.14K | -203.62%-20.01K | 35.70%-18.37K | -26.69%-11.7K | -267.66%-44.05K | 53.75%-30.47K | 168.09%19.31K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.